EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.615
https://www.valueinhealthjournal.com/article/S1098-3015(22)00816-6/fulltext
Title :
EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00816-6&doi=10.1016/j.jval.2022.04.615
First page :
Section Title :
Open access? :
No
Section Order :
10552